Anti-Urkinase Plasminogen Activator

Host: Mouse

Isotype: IgG1

Immunogen: the B chain of human urokinase plasminogen activator

Form: Lyophilized

Formulation: Lyophilized from 20 mM NH4HCO3, 100 µg BSA.

Preservative: None

Positive Control: Concentrated conditioned medium from dexamethasone-treated HT-1080 cells

Comments: Recognizes uPA/PAI complexes in dexamethasone-treated HT-1080 cells and carcinoma tissue. Sold under license of U.S. Patent 5,422,245.

Ref.: Rosenquist, C., et al. 1993. Breast Cancer Res. and Treatment 28, 223. Foekens, J. A., et al. 1992. Cancer Res. 52, 6101. Andreasen, P. A., et al. 1990. Mol. Cell. Endocrinol. 68, 1. Blasi, F. and Verde, P. 1990. in Seminars in Cancer Biology, ed. M. M. Gottesman. Vol. 1, 153. Duffy, M. J., et al. 1990. Cancer Res. 50, 6827. Jänicke, F., et al. 1990. Fibrinolysis 4, 69. Blasi, F., et al. 1987. J. Cell Biol. 104, 801.

Sold under license of U.S. Patent 5,422,245.